Rizatriptan Benzoate
Product manufactured by Aurobindo Pharma Limited
Indications and Purposes
| 1 Indications And Usage Rizatriptan Benzoate Orally Disintegrating Tablets Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults And In Pediatric Patients 6 To 17 Years Old. Limitations Of Use Rizatriptan Benzoate Orally Disintegrating Tablets Should Only Be Used Where A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response For The First Migraine Attack Treated With Rizatriptan Benzoate Orally Disintegrating Tablets, The Diagnosis Of Migraine Should Be Reconsidered Before Rizatriptan Benzoate Orally Disintegrating Tablets Are Administered To Treat Any Subsequent Attacks. Rizatriptan Benzoate Orally Disintegrating Tablets Are Not Indicated For Use In The Management Of Hemiplegic Or Basilar Migraine [See Contraindications (4) ] . Rizatriptan Benzoate Orally Disintegrating Tablets Are Not Indicated For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Rizatriptan Benzoate Orally Disintegrating Tablets Have Not Been Established For Cluster Headache. Rizatriptan Benzoate Is A Serotonin (5-Ht) 1b/1d Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults And In Pediatric Patients 6 To 17 Years Of Age (1) Limitations Of Use : Use Only After Clear Diagnosis Of Migraine Has Been Established (1) Not Indicated For The Prophylactic Therapy Of Migraine (1) Not Indicated For The Treatment Of Cluster Headache (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Rizatriptan Benzoate |
|
ZINC1011 |